In our study, we demonstrated that the remarkable effectiveness to reduce cardiac fibrosis in DCM by administration of THC was achieved, at least partially, by the inhibition of the TGFβ1/Smad3 profibrotic signaling pathway via SIRT1-induced attenuation of ROS generation. This evidence concerns the gene TGFB1 and familial dilated cardiomyopathy.